AsymBio Kicks Off Construction of Fengxian R&D Building to Establish a Full-Lifecycle, One-Stop Biologics Service Ecosystem

Summary

AsymBio, a biologics-focused CDMO and subsidiary of Asymchem Group, has announced the official groundbreaking of construction for a new R&D building in Shanghai to expand its biologics service capabilities.